Groupe Servibio S.A.S.

What Groupe Servibio S.A.S. does

Groupe Servibio S.A.S. is a French privately held (SAS) in vitro diagnostics distributor and light manufacturer founded in December 1983 and headquartered in Les Ulis, on a facility expanded by 417 m² in December 2023. Following its December 2011 acquisition by owner-director Marc Bourlioux (Docteur en Pharmacie), the company restructured into a multi-brand specialty IVD platform; it further extended scope through the July 2022 acquisition of KeyOfLab, which was physically co-located to the Servibio site in January 2024.

The portfolio spans rapid immunochromatographic tests, molecular biology (GeneSign/VIASURE real-time PCR kits, extraction and instruments), point-of-care automated immunofluorescence (Boditech AFIAS series), LAMP isothermal amplification (eazyplex), turbidimetric fecal biomarkers (Turbilatex), latex agglutination (Prolex), autoimmunity immunofluorescence (BioSystems iPro/iMLD), veterinary diagnostics (VetSign, Youseq, EasyPara), urinalysis (UriSign), life-science reagents (Microbank, ZeptoMetrix), and internal/external quality controls (INSTAND, UK NEQAS, ESfEQA, Diamex). Products are CE-IVD marked under EU IVDR 2017/746 and manufactured or distributed under ISO 13485:2016 and ISO 14001:2015 certifications. The company is also an exclusive French distributor for multiple international OEMs (Certest, Boditech, ZeptoMetrix, Immundiagnostik, BioSystems, Prolab, Youseq, INSTAND, UK NEQAS, ESfEQA, Diamex, Sacace, Trinity Biotech, Alltest, Vedalab).

Commercial operations run on a direct-sales motion into French hospitals, clinical and private laboratories, emergency services, and veterinary laboratories; key economics derive from one-time product and instrument sales, multi-year supply contracts, and value-add through ISO/IEC 17043-accredited external quality assessment programs. Pricing is not publicly disclosed. The company remains a tightly held single-owner enterprise with no disclosed institutional capital, 14 employees, and €133,728 of share capital.

Name

Groupe Servibio S.A.S.

Legal name

SAS Groupe Servibio

Website

https://servibio.com

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

11–50 employees

Short description

Groupe Servibio S.A.S. is a French specialty in vitro diagnostics (IVD) distributor and light manufacturer, supplying molecular, point-of-care, turbidimetric, parasitology, veterinary, and quality-control products to hospitals, clinical laboratories, emergency services, and veterinary labs under exclusive French distribution partnerships.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics Distribution

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (6215)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• In vitro diagnostics
• Molecular biology reagents
• Point-of-care testing
• Medical laboratory supplies
• Rapid diagnostic tests

Headquarters

HQ city

Les Ulis

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. In Vitro Diagnostic Products Distribution: Groupe Servibio manufactures and distributes a comprehensive portfolio of IVD products including rapid tests, molecular biology reagents, immunofluorescence assays, turbidimetry tests, LAMP kits, latex agglutination tests, and quality controls to laboratories and healthcare facilities in France.
2. Point-of-Care Diagnostic Systems: Sale of automated POCT analyzers (AFIAS series) with配套 reagents for cardiac markers, infectious diseases, oncology, and endocrinology testing at point-of-care settings
3. Quality Control Products: Distribution of internal quality controls (CQI) and external quality assessments (EEQ) for infectious serology and molecular biology laboratories
4. Veterinary Diagnostics: VetSign product line including Youseq PCR kits and parasitology concentrators for veterinary laboratories

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Groupe Servibio manufactures and distributes a comprehensive portfolio of in vitro diagnostic (IVD) products in France, including rapid immunochromatographic tests (e.g., Certest ResisCheck Carbapenemases), molecular biology PCR reagents and instruments (GeneSign/VIASURE), automated point-of-care immunofluorescence analyzers (AFIAS), turbidimetric fecal biomarker reagents (Turbilatex), LAMP isothermal amplification kits (eazyplex), latex agglutination tests, immunofluorescence autoimmunity slides, parasitology concentration systems (EasyPara), urinalysis strips, cryopreservation systems (Microbank), quality controls, and veterinary diagnostics. Products are CE-IVD marked under EU IVDR 2017/746 and sold exclusively to professional healthcare customers.

Product overview

Groupe Servibio S.A.S. is a French in vitro diagnostics (IVD) distributor and manufacturer established in 1983, acquired by Marc Bourlioux in December 2011, and headquartered in Les Ulis, France. The company operates as a multi-brand diagnostic portfolio covering rapid tests, molecular biology (GeneSign/VIASURE), point-of-care immunofluorescence (Boditech AFIAS), turbidimetric fecal biomarkers (Turbilatex/Certest), LAMP isothermal amplification (eazyplex), latex agglutination, immunofluorescence autoimmunity (BioSystems), veterinary diagnostics (VetSign), parasitology (ParaSign), urinalysis (UriSign), life science research reagents (Microbank, ZeptoMetrix), quality controls (IQC/EQA), and HIV p24 ELISA. The portfolio is organized into branded sub-ranges that serve distinct diagnostic disciplines, distributed alongside third-party biochemistry analyzers (Abbott, Roche, Siemens, Beckman Coulter) and laboratory information systems. In July 2022, Groupe Servibio acquired KeyOfLab, expanding its molecular and specialty diagnostics capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Certest ResisCheck Carbapenemases

Quantifiable outcome

• Results in 3-15 minutes for point-of-care tests
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration11 records

Feature6 records

Partnerships

Eleven partnerships are on record, tiered core.

• KeyOfLabcoreStrategic or Co-development Partner · 1 July 2022KeyOfLab was acquired in July 2022, strengthening Groupe Servibio's expertise and expanding its product portfolio. KeyOfLab subsidiary relocated to Groupe Servibio site in January 2024.
• Certest BioteccoreTechnology or IntegrationCertest is a key partner providing rapid carbapenemase detection tests (ResisCheck), Turbilatex reagents, and VIASURE PCR kits. Servibio distributes Certest products in France including the Certest ResisCheck carbapenemase detection test compliant with IVDR.
• BoditechcoreTechnology or IntegrationBoditech provides the AFIAS series of automated point-of-care immunofluorescence analyzers (AFIAS-1, 3, 6, 10) for rapid diagnostic testing in hospitals and laboratories.
• ImmundiagnostikcoreTechnology or IntegrationImmundiagnostik provides research and diagnostic immunology and gastrointestinal pathology products distributed by Servibio.
• BioSystemscoreTechnology or IntegrationBioSystems provides automated slide preparation (iPro v-2) and immunofluorescence microscopy (iMLD) solutions for autoimmune disease diagnostics.
• ProlabcoreTechnology or IntegrationProlab provides Microbank cryopreservation systems for long-term storage of bacteria, yeast, and filamentous fungi.
• ZeptoMetrixcoreTechnology or IntegrationZeptoMetrix provides NATtrol molecular quality control products and ELISA kits including HIV-1 p24 antigen detection. Servibio is the official distributor of ZeptoMetrix kits in France.
• UK NEQAScoreTechnology or IntegrationUK NEQAS provides external quality assessment programs with 50+ years of experience in autoimmune, immunochemistry, allergy, and POC testing for laboratory accreditation support.
• INSTANDcoreTechnology or IntegrationINSTAND offers over 350 external quality assessment programs covering microbiology, virology, genetics, clinical chemistry, hematology, and immunology.
• DiamexcoreTechnology or IntegrationDiamex provides internal quality control solutions with ready-to-use plasma samples for infectious serology testing, compatible with major automated platforms.
• YouseqcoreTechnology or IntegrationYouseq provides a broad range of qPCR detection kits for human pathogens, veterinary diseases, and other applications, used in over 100 countries worldwide.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Emerging players

• Boditech Med: South Korean manufacturer of AFIAS automated point-of-care immunofluorescence analyzers distributed by Servibio in France. Comparable as the upstream manufacturer whose products represent a major portion of Servibio's POCT/emergency-services revenue line.
• Immundiagnostik AG: German IVD company offering immunology, gastroenterology, and specialty biomarker assays distributed in part by Groupe Servibio in France. Comparable as an upstream partner whose product line overlaps directly with the Turbilatex and fecal biomarker segments of Servibio's portfolio.
• Certest Biotec: Spanish IVD manufacturer of rapid tests, Turbilatex turbidimetric reagents, and VIASURE PCR kits, distributed by Servibio in France. Comparable as a key upstream partner whose products underpin Servibio's carbapenemase detection, fecal biomarker, and molecular biology lines.

Regional players

• Sebia: French-headquartered IVD company specializing in protein electrophoresis and capillary electrophoresis for clinical diagnostics. Comparable as a French-rooted specialty diagnostics player with a similar laboratory-focused customer base, though narrower in product scope.

Broad incumbents

• Stago: French-headquartered IVD company specializing in hemostasis diagnostics. Comparable as a major French IVD incumbent serving similar hospital and private laboratory customers, though operating in a narrower specialty (coagulation) than Servibio's multi-discipline portfolio.
• bioMérieux: Global French IVD leader in microbiology and clinical diagnostics. Comparable as a major French IVD player operating in the same microbiology and infectious disease diagnostics space, though at vastly larger scale and with proprietary manufacturing rather than distribution.
• Eurofins Scientific: Major European bioanalytical testing and diagnostics group with significant French laboratory operations. Comparable as a much larger incumbent that competes for the same French clinical and microbiology laboratory customers, though Eurofins' primary business is lab services rather than IVD product distribution.

Direct peers

• Biosynex: French diagnostics company focused on rapid tests, molecular biology, and immunology. Comparable as a similarly-sized French IVD distributor with overlapping product categories (rapid tests, infectious disease, immunology) and similar customer base of hospital and private labs.
• Erba Diagnostics (Erba Mannheim): European-headquartered IVD company offering clinical chemistry, immunology, hematology, and rapid test products through a multi-region distribution model. Comparable as a multi-discipline IVD portfolio company with similar product breadth and channel structure to Servibio.
• ELITech Group: French-headquartered IVD company distributing and manufacturing clinical chemistry, microbiology, and molecular diagnostics products across Europe. Closely comparable as a mid-sized European IVD specialist with a multi-brand distribution-plus-manufacturing model similar to Groupe Servibio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/groupe-servibio-s-a-s-

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Groupe Servibio S.A.S.